Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

24.00
-0.6100-2.48%
Post-market: 24.000.00000.00%19:30 EDT
Volume:1.41M
Turnover:34.07M
Market Cap:781.33M
PE:18.90
High:25.46
Open:24.85
Low:23.93
Close:24.61
52wk High:50.79
52wk Low:23.93
Shares:32.56M
Float Shares:31.37M
Volume Ratio:1.82
T/O Rate:4.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.73
ROE:17.61%
ROA:5.75%
PB:2.51
PE(LYR):13.87

Loading ...

Collegium Pharmaceutical is Maintained at Overweight by Barclays

Dow Jones
·
Aug 19

Barclays Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)

TIPRANKS
·
Aug 19

Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement

MT Newswires Live
·
Aug 13

Collegium Announces $50 Million Accelerated Share Repurchase Program

THOMSON REUTERS
·
Aug 13

Collegium Pharmaceutical Price Target Cut to $43.00/Share from $45.00 by Piper Sandler

Dow Jones
·
Aug 08

U.S. Research Roundup-Airbnb, Expedia Group, Parker-Hannifin

Reuters
·
Aug 07

Analysts’ Top Healthcare Picks: Collegium Pharmaceutical (COLL), Adicet Bio (ACET)

TIPRANKS
·
Aug 07

Collegium Pharmaceutical Down over 13%, on Track for Largest Percent Decrease Since May 2024

Dow Jones
·
Aug 06

Collegium Pharmaceutical Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Collegium Pharmaceutical Updates Guidance After AZSTARYS Acquisition

TIPRANKS
·
Aug 06

GUIDANCE: (COLL) Collegium Pharmaceutical Expects 2026 Net Product Revenue Range $825M to $855M

MT Newswires Live
·
Aug 06

Collegium Turns to GAAP Net Loss of $15.1 Million in Q2 FY26; Revenue Rises 6% to $199.9 Million

Reuters
·
Aug 06

Collegium Pharmaceutical Q2 Adj. EPS $1.92 Beats $1.72 Estimate, Sales $199.878M Miss $201.206M Estimate

Benzinga Earnings
·
Aug 06

Collegium Pharmaceutical Q2 Adjusted EPS USD 1.92 VS. Ibes Estimate USD 1.72

THOMSON REUTERS
·
Aug 06

Collegium Pharmaceutical Outlook FY Adjusted Ebitda USD 445-470 Million

THOMSON REUTERS
·
Aug 06

Collegium Pharmaceutical Outlook FY Revenue USD 825-855 Million

THOMSON REUTERS
·
Aug 06

How Collegium's Quarterly Beat but Softer Outlook Could Reframe Collegium Pharmaceutical (COLL) Investors

Simply Wall St.
·
Jul 29

Collegium Pharmaceutical to Report Q2 2026 Results, Host Earnings Call

Reuters
·
Jul 23

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

GlobeNewswire
·
Jul 20

Engene Names Michael Heffernan Board Chairman as Richard Glickman Steps Down

Reuters
·
Jul 16